Gain Therapeutics, Inc. (NASDAQ:GANX) Financings

Gain Therapeutics, Inc.

Financings

RaiseDate
Public offering of shares of common stock and warrants to purchase common stock
Announced: about US$7M · US$3.11 a share · 1 warrant at US$1.65 for 60 months · Newbridge Securities Corporation
Dealers: Newbridge Securities Corporation (lead)
Use of proceeds: Clinical and nonclinical development of lead candidate GT-02287 for neurodegenerative diseases including GBA1 Parkinson's, and general corporate purposes
Jul 16, 2025

Read by 6ix AI from the company's releases